125I-α-Conotoxin MII Identifies a Novel Nicotinic Acetylcholine Receptor Population in Mouse Brain
The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
α-Conotoxin MII (CtxMII), a peptide toxin from the venom of the predatory cone snail Conus magus, displays an unusual nicotinic pharmacology. Specific binding of a radioiodinated derivative (125I-α-CtxMII) was identified in brain region homogenates and tissue sections. Quantitative autoradiography indicated that 125I-α-CtxMII binding sites have an unique pharmacological profile and distribution in mouse brain, being largely confined to the superficial layers of the superior colliculus, nigrostriatal pathway, optic tract, olivary pretectal, and mediolateral and dorsolateral geniculate nuclei. Expression of α-CtxMII binding sites in the nigrostriatal pathway, combined with evidence for α-CtxMII-sensitivity of nicotine-induced [3H]dopamine release in rodent striatal preparations indicates that 125I-α-CtxMII binding nicotinic acetylcholine receptors are likely to be physiologically important. Unlabeled α-CtxMII potently (Ki 10 μM) interacted with 125I-α-bungarotoxin and (−)-[3H]nicotine binding sites, confirming this compound9s novel nicotinic pharmacology. Quantitative autoradiography revealed that α-CtxMII binds with high affinity at a subset of [3H]epibatidine binding sites with relatively low cytisine affinity (“cytisine-resistant” sites), resolving [3H]epibatidine binding into three different populations, each probably corresponding to a receptor subtype. The majority population seems to correspond to that which binds nicotine and cytisine with high affinity (“cytisine-sensitive” sites). Comparison of the cytisine-resistant population9s distribution with that of α3 subunit mRNA expression suggests that the fractions both more and less sensitive to α-CtxMII probably contain the α3 subunit, perhaps in combination with different β subunits.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Yung-Chi, C., & Prusoff, W. H. (1973) · Biochemical Pharmacology · doi:10.1016/0006-2952(73)90196-2 · Cited by 12,922
Presynaptic nicotinic ACh receptors
Wonnacott, S. (1997) · Trends in Neurosciences · doi:10.1016/s0166-2236(96)10073-4 · Cited by 1,308 · cited 1×
“In the central nervous system, many of these neuronal nAChRs seem to be presynaptic, where they modulate the release of neurotransmitters such as dopamine, norepinephrine, acetylcholine, and g-aminobutyric acid with differential pharmacologies (Wonnacott, 1997).”
Flores, C. M., Rogers, S. W., Pabreza, L. A., Wolfe, B. B., & Kellar, K. J. (1992) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)08832-7 · Cited by 880
Nicotine binding and nicotinic receptor subunit RNA after chronic nicotine treatment
Marks, M., Pauly, Jr., Gross, S., Deneris, E., Hermans-Borgmeyer, I., Heinemann, S., & Collins, A. (1992) · The Journal of Neuroscience · doi:10.1523/jneurosci.12-07-02765.1992 · Cited by 551
Self-citationLe Novere, N., Zoli, M., & Changeux, J. (1996) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.1996.tb01206.x · Cited by 385
Cited by
Guidelines on nicotine dose selection for in vivo research
Matta, S. G., Balfour, D. J., Benowitz, N. L., Boyd, R. T., Buccafusco, J. J., Caggiula, A. R., Craig, C. R., Collins, A. C., Damaj, M. I., Donny, E. C., et al. (2007) · Psychopharmacology · doi:10.1007/s00213-006-0441-0 · Cited by 824
“Investigators are referred to additional resources (e.g., Benowitz 1998; Tyndale and Sellers 2001; Whiteaker et al. 2000a,b) and a recent comprehensive review (Hukkanen et al. 2005) for specific details and additional references on nicotine pharmacokinetics and pharmacodynamics.”
Self-citationSalminen, O., Murphy, K. L., McIntosh, J. M., Drago, J., Marks, M. J., Collins, A. C., & Grady, S. R. (2004) · Molecular Pharmacology · doi:10.1124/mol.65.6.1526 · Cited by 405
Self-citationGovind, A. P., Vezina, P., & Green, W. N. (2009) · Biochemical Pharmacology · doi:10.1016/j.bcp.2009.06.011 · Cited by 338
Pons, S., Fattore, L., Cossu, G., Tolu, S., Porcu, E., McIntosh, J. M., Changeux, J. P., Maskos, U., & Fratta, W. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.3918-08.2008 · Cited by 312
“The [ 125I]conotoxin MII binding procedure was adapted from Whiteaker et al. (2000).”
MethodSelf-citationThe subtypes of nicotinic acetylcholine receptors on dopaminergic terminals of mouse striatum
Grady, S. R., Salminen, O., Laverty, D. C., Whiteaker, P., McIntosh, J. M., Collins, A. C., & Marks, M. J. (2007) · Biochemical Pharmacology · doi:10.1016/j.bcp.2007.07.032 · Cited by 252
Self-citation
Metadata
- Authors
- Whiteaker, P., McIntosh, J. M., Luo, S., Collins, A. C., & Marks, M. J.
- Venue
- Molecular Pharmacology
- Publisher
- Elsevier BV
- Published
- 2000-05
- Volume
- 57
- Issue
- 5
- Pages
- 913-925
- ISSN
- 0026-895X (ISSN-L)
- OpenAlex
- W4405989070
- Cited by
- 100
- References
- 5
- FWCI
- 1.58
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: 125I-α-Conotoxin MII Identifies a Novel Nicotinic Acetylcholine Receptor Population in Mouse Brain. https://app.cochat.ai/papers/10.1016/s0026-895x(24)26500-7
- The paper
- Whiteaker, P., McIntosh, J. M., Luo, S., Collins, A. C., & Marks, M. J. (2000). 125I-α-Conotoxin MII Identifies a Novel Nicotinic Acetylcholine Receptor Population in Mouse Brain. Molecular Pharmacology. https://doi.org/10.1016/s0026-895x(24)26500-7
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.